HCA Healthcare (HCA) Competitors

HCA Healthcare has higher revenue and earnings than The Ensign Group. HCA Healthcare is trading at a lower price-to-earnings ratio than The Ensign Group, indicating that it is currently the more affordable of the two stocks.

In the previous week, The Ensign Group had 10 more articles in the media than HCA Healthcare. MarketBeat recorded 19 mentions for The Ensign Group and 9 mentions for HCA Healthcare. The Ensign Group's average media sentiment score of 0.64 beat HCA Healthcare's score of 0.55 indicating that The Ensign Group is being referred to more favorably in the media.

The Ensign Group has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market. Comparatively, HCA Healthcare has a beta of 1.12, meaning that its stock price is 12% more volatile than the broader market.

The Ensign Group currently has a consensus price target of $216.75, suggesting a potential upside of 29.21%. HCA Healthcare has a consensus price target of $503.00, suggesting a potential upside of 21.72%. Given The Ensign Group's stronger consensus rating and higher probable upside, research analysts clearly believe The Ensign Group is more favorable than HCA Healthcare.

HCA Healthcare has a net margin of 8.89% compared to The Ensign Group's net margin of 6.89%. The Ensign Group's return on equity of 16.78% beat HCA Healthcare's return on equity.

The Ensign Group pays an annual dividend of $0.26 per share and has a dividend yield of 0.2%. HCA Healthcare pays an annual dividend of $3.12 per share and has a dividend yield of 0.8%. The Ensign Group pays out 4.2% of its earnings in the form of a dividend. HCA Healthcare pays out 10.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. The Ensign Group has raised its dividend for 18 consecutive years and HCA Healthcare has raised its dividend for 6 consecutive years.

96.1% of The Ensign Group shares are held by institutional investors. Comparatively, 62.7% of HCA Healthcare shares are held by institutional investors. 4.0% of The Ensign Group shares are held by company insiders. Comparatively, 1.5% of HCA Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

HCA Healthcare has a beta of 1.12, meaning that its share price is 12% more volatile than the broader market. Comparatively, Centene has a beta of 1.07, meaning that its share price is 7% more volatile than the broader market.

HCA Healthcare has a net margin of 8.89% compared to Centene's net margin of -3.25%. Centene's return on equity of 5.57% beat HCA Healthcare's return on equity.

62.7% of HCA Healthcare shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 1.5% of HCA Healthcare shares are owned by company insiders. Comparatively, 0.4% of Centene shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

HCA Healthcare presently has a consensus target price of $503.00, indicating a potential upside of 21.72%. Centene has a consensus target price of $60.78, indicating a potential downside of 7.18%. Given HCA Healthcare's stronger consensus rating and higher possible upside, equities research analysts plainly believe HCA Healthcare is more favorable than Centene.

HCA Healthcare has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than HCA Healthcare, indicating that it is currently the more affordable of the two stocks.

In the previous week, HCA Healthcare and HCA Healthcare both had 9 articles in the media. HCA Healthcare's average media sentiment score of 0.55 beat Centene's score of -0.07 indicating that HCA Healthcare is being referred to more favorably in the media.

HCA Healthcare has a beta of 1.12, suggesting that its stock price is 12% more volatile than the broader market. Comparatively, Encompass Health has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market.

HCA Healthcare has higher revenue and earnings than Encompass Health. HCA Healthcare is trading at a lower price-to-earnings ratio than Encompass Health, indicating that it is currently the more affordable of the two stocks.

HCA Healthcare currently has a consensus price target of $503.00, indicating a potential upside of 21.72%. Encompass Health has a consensus price target of $143.86, indicating a potential upside of 34.93%. Given Encompass Health's stronger consensus rating and higher possible upside, analysts clearly believe Encompass Health is more favorable than HCA Healthcare.

HCA Healthcare pays an annual dividend of $3.12 per share and has a dividend yield of 0.8%. Encompass Health pays an annual dividend of $0.76 per share and has a dividend yield of 0.7%. HCA Healthcare pays out 10.7% of its earnings in the form of a dividend. Encompass Health pays out 12.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. HCA Healthcare has raised its dividend for 6 consecutive years and Encompass Health has raised its dividend for 2 consecutive years. HCA Healthcare is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

62.7% of HCA Healthcare shares are owned by institutional investors. Comparatively, 97.3% of Encompass Health shares are owned by institutional investors. 1.5% of HCA Healthcare shares are owned by insiders. Comparatively, 1.8% of Encompass Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Encompass Health has a net margin of 10.04% compared to HCA Healthcare's net margin of 8.89%. Encompass Health's return on equity of 18.28% beat HCA Healthcare's return on equity.

In the previous week, HCA Healthcare had 4 more articles in the media than Encompass Health. MarketBeat recorded 9 mentions for HCA Healthcare and 5 mentions for Encompass Health. Encompass Health's average media sentiment score of 1.28 beat HCA Healthcare's score of 0.55 indicating that Encompass Health is being referred to more favorably in the news media.

In the previous week, Elevance Health had 5 more articles in the media than HCA Healthcare. MarketBeat recorded 14 mentions for Elevance Health and 9 mentions for HCA Healthcare. Elevance Health's average media sentiment score of 1.28 beat HCA Healthcare's score of 0.55 indicating that Elevance Health is being referred to more favorably in the news media.

HCA Healthcare has a beta of 1.12, meaning that its share price is 12% more volatile than the broader market. Comparatively, Elevance Health has a beta of 0.67, meaning that its share price is 33% less volatile than the broader market.

62.7% of HCA Healthcare shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 1.5% of HCA Healthcare shares are owned by insiders. Comparatively, 0.3% of Elevance Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

HCA Healthcare pays an annual dividend of $3.12 per share and has a dividend yield of 0.8%. Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.7%. HCA Healthcare pays out 10.7% of its earnings in the form of a dividend. Elevance Health pays out 29.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. HCA Healthcare has increased its dividend for 6 consecutive years and Elevance Health has increased its dividend for 14 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

HCA Healthcare presently has a consensus target price of $503.00, indicating a potential upside of 21.72%. Elevance Health has a consensus target price of $419.16, indicating a potential upside of 2.44%. Given HCA Healthcare's higher possible upside, equities analysts plainly believe HCA Healthcare is more favorable than Elevance Health.

HCA Healthcare has a net margin of 8.89% compared to Elevance Health's net margin of 2.62%. Elevance Health's return on equity of 15.58% beat HCA Healthcare's return on equity.

HCA Healthcare has higher earnings, but lower revenue than Elevance Health. HCA Healthcare is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.